IMC Chicago’s Biohaven BHVN Stock Holding History

IMC Chicago’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.25M	Buy	84,201 +62,121	+281%	+$669K	﹤0.01%	3574
2026 Q1	$187K	Sell	22,080 -27,255	-55%	-$298K	﹤0.01%	5058
2025 Q4	$557K	Buy	+49,335	New	+$611K	﹤0.01%	3407

Other funds holding BHVN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IMC Chicago's BHVN Position: Q2 2026 in Review

IMC Chicago increased its Biohaven (BHVN) stake by 281% in Q2 2026, buying an estimated $669K and bringing the position to 84,201 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #3574.

IMC Chicago first reported a position in BHVN in Q4 2025 and has held it in 3 quarters since. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

IMC Chicago held 84,201 shares of Biohaven worth $1.25M as of Q2 2026.
IMC Chicago bought 62,121 Biohaven shares in Q2 2026, an estimated $669K.
Biohaven made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #3574 holding.
IMC Chicago first reported a position in Biohaven in Q4 2025 and has held it in 3 quarters since.
296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.